There was an interview with Paul from a number of years ago. During the interview he said something along the lines of.... A really well run Biotech company can get an ordinary drug to market, and a poorly run Biotech will struggle to get a blockbuster drug to market....Which one is Imugene?
Also, he said that the game plan is to see a drug at Phase 2.
Ann: Change of Director's Interest Notice - PH, page-149
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(0.91%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $314.3K | 5.720M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 3946291 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 183762 | 7 |
View Market Depth
| Last trade - 13.39pm 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |